A Study to Evaluate ELX/TEZ/IVA on Cough and Physical Activity in Subjects With Cystic Fibrosis (CF)

  • STATUS
    Not Recruiting
  • days left to enroll
    76
  • participants needed
    100
  • sponsor
    Vertex Pharmaceuticals Incorporated
Updated on 13 June 2022
fibrosis
forced expiratory volume
ivacaftor
tezacaftor
elexacaftor

Summary

This study will evaluate the effects of elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) on cough and physical activity using wearable technology in CF participants.

Details
Condition Cystic Fibrosis
Treatment IVA, ELX/TEZ/IVA
Clinical Study IdentifierNCT04969224
SponsorVertex Pharmaceuticals Incorporated
Last Modified on13 June 2022

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note